
Aequs shares crashed nearly 19% on Tuesday, hitting their lowest level in over four months since June 19. As of 9:40 am, the stock was trading at ₹211.30, down 12.9% or ₹31.30 from the previous close of ₹242.40. Earlier in the session, Aequs shares fell to ₹196.50, marking a decline of 18.93% from the previous close. The selloff came after the aerospace company's consolidated net loss more than doubled to ₹52.3 crore in Q2 FY27 from ₹20.59 crore a year earlier, prompting brokerages to sound the alarm and slash target prices. According to LiveMint, the stock has declined 33% in less than a month after hitting a lifetime high of ₹295 earlier this month. The stock closed 9.90% lower to ₹218.40 on the NSE after the company announced its September-quarter results post market hours on Monday. The stock opened at ₹213.55 on BSE, touched an intraday high of ₹218.15, and hit a low of ₹196.55 per share.
Contract manufacturing company Aequs reported a consolidated net loss of ₹52.3 crore for Q2 FY27, more than doubling from the ₹20.59 crore loss recorded in Q2 FY26, despite achieving a 45.3% year-on-year increase in revenue to ₹409.1 crore. The company's EBITDA declined 45% year-on-year to ₹24.5 crore from ₹44.3 crore, with EBITDA margin contracting to 6.02% from 15.2% in the corresponding quarter last year. The results showed sequential improvement with EBITDA up 8% from Q1's ₹33.1 crore, though the year-on-year comparison reflects consumer electronics costs now being expensed following commencement of commercial operations. For the first half of FY27, consolidated net loss widened to ₹106 crore from around ₹17 crore in the year-ago period, while revenue during April-September increased 50% YoY to ₹805 crore. The company's total expenditure increased 56% YoY to ₹395 crore, adding to pressure on the bottom line.
The aerospace segment emerged as the primary growth driver, with revenue growing 44% year-on-year to ₹351.4 crore in Q2 FY27 and contributing 86% of Q2FY27 revenue. As reported in the latest financial results, for the first half of FY27, aerospace revenue increased 42% to ₹673.6 crore, with aerospace EBITDA rising 24% year-on-year to ₹78.3 crore in the second quarter. The company's aerospace order book reached $1.1 billion, marking a 9% increase over the previous quarter, while Aequs secured its first serial-production contract with Safran for A320 aircraft wheels, marking a tenure exceeding 15 years. The company added 238 parts to its aerospace portfolio during the quarter, taking the range to 5,978 stock-keeping units (SKUs). The company installed nine computer numerical control (CNC) machines, bringing the segment's total to 229, with annualised machining and molding capacity across the Company increasing to 4.93 million hours. The company is expanding beyond aerostructures into engine and landing gear components at Hosur, with the aerospace business reporting an EBITDA margin of 22%. According to LiveMint, aerospace capacity utilisation reached 69%, rising to 76% at its India operations, with aerospace inventory expected to normalise around Q1 FY28.
Despite strong growth in aerospace, the consumer business faced significant headwinds with revenue increasing 52% year-on-year to ₹57.7 crore in Q2 FY27, but declining 21% quarter-on-quarter from ₹734 crore in Q1FY27. The consumer segment's EBITDA loss widened to ₹40.1 crore in Q2 from ₹36.1 crore in Q1, with the first-half loss standing at ₹76.3 crore. According to the company's latest statement, the volume ramp progressed slower than anticipated due to extended qualification timelines and supply chain constraints. The divergence between aerospace and consumer segments remains the primary driver of profitability volatility, with the company explicitly withdrawing its consumer EBITDA breakeven target without providing a revised timeline. JM Financial noted that the key surprise was the sequential decline in consumer sales (-21% QoQ) and utilisation (17% down from 22% in Q1 FY27). The consumer segment recorded revenue of ₹87 crore in Q2 FY27, with first-half revenue at ₹168 crore compared to ₹63 crore in the corresponding period last year. The brokerage stated that EBITDA breakeven guidance for the consumer segment has been pushed beyond the originally target of Q4FY27.
The company approved a ₹650 crore promoter-group investment through preferential warrants to fund capacity expansion, joint ventures, working capital and the Hosur aerospace ecosystem. Nuvama has maintained its 'BUY' rating on Aequs and retained its discounted cash flow (DCF)-based share price target of ₹444, implying an upside potential of 110.13% at the current market price of ₹211.30. However, JM Financial Institutional Securities maintained its 'Reduce' rating despite raising its target price to ₹245 from ₹220, stating the company's longer-term growth prospects and planned investments. The brokerage noted that Aequs' Q2FY27 EBITDA came in at ₹13.9 crore, down 51% YoY and 6% sequentially, missing its estimate by around 50%. JM Financial highlighted that EBITDA margins in the aerospace segment moderated, even as sales were modestly ahead of estimates, while noting that while the overall results were disappointing, longer-term prospects remain strong as Aequs moves ahead with establishing the aerospace hub at Hosur. The brokerage slightly lowered its FY27 and FY28 EBITDA estimates factor in weakness in the consumer business, but raised its target price after factoring in higher capital expenditure, sales and EBITDA for FY30 and FY31.
For the half-year ended September 30, 2026, Aequs posted revenue of ₹8,046 crore, up 50% year-on-year from ₹5,372 crore in H1FY26. However, EBITDA for H1FY27 stood at ₹460 crore, down 45% from ₹841 crore, with EBITDA margin contracting to 6% from 16% in H1FY26. The net loss for H1FY27 widened to ₹1,054 crore from ₹167 crore in H1FY26, reflecting consumer electronics operating costs now being expensed following commencement of commercial operations. The company's total assets stood at ₹27,739 crore as of September 30, 2026, with cash and cash equivalents at ₹1,710 crore and net debt/equity ratio moving to 0.5x from 0.2x in FY26. Including proportionate joint venture contributions, H1 revenue reached ₹8,781 crore, up 48% YoY, with EBITDA at ₹638 crore and a margin of approximately 7%. Management noted that production ramp-ups in the company's business can occasionally lead to delays, given the nature of its operations, while emphasizing that the company does not anticipate near-term order book risks.